Error in Discussion Section | JAMA Neurology | JAMA Network
[Skip to Navigation]
Sign In
March 18, 2019

Error in Discussion Section

JAMA Neurol. 2019;76(5):625-626. doi:10.1001/jamaneurol.2019.0475

In the Original Investigation titled “Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial,”1 published online February 7, 2019, there was an error in the Discussion section. The second-to-last sentence before the Limitations section should read: “Myocardial infarction and stroke are very costly, so the balance of NNTs for beneficial outcomes and numbers needed to harm for adverse outcomes would suggest cost utility for pioglitazone, but we have not yet conducted a cost-utility calculation.” This article was corrected online.

Spence  JD, Viscoli  CM, Inzucchi  SE; IRIS Investigators.  Pioglitazone therapy in patients with stroke and prediabetes: a post hoc analysis of the IRIS randomized clinical trial  [published online February 7, 2019].  JAMA Neurol. doi:10.1001/jamaneurol.2019.0079Google Scholar